
Pharming Announces U.S. FDA Approval of Joenja as the First and Only Treatment Indicated for APDS By Investing.com
Pharming (PHAR) Announces US FDA Approval of Joenja® (leniolisib) as the First and Only Treatment Indicated for APDS (Updated – March 24, 2023 2:33 p.m. EDT) Pharming Group S.A. (“Agriculture” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that the US Food and Drug Administration (FDA) has approved Joenja® (leniolisib) for the treatment of activated…